Insmed Inc
F:IM8N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Insmed Inc
F:IM8N
|
US |
|
Crane NXT Co
NYSE:CXT
|
US |
|
Public Service Enterprise Group Inc
NYSE:PEG
|
US |
|
S
|
SM Energy Co
F:SJL
|
US |
|
T
|
Titanium Transportation Group Inc
F:I9V
|
CA |
|
Aviva PLC
F:GU81
|
UK |
|
China Mobile Ltd
SSE:600941
|
CN |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
US |
|
Engie SA
OTC:ENGQF
|
FR |
|
Lowe's Companies Inc
NYSE:LOW
|
US |
|
L
|
L'Oreal SA
XHAM:LOR
|
FR |
Wall St Price Targets
IM8N Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for
IM8N is 229.59 EUR with a low forecast of 191 EUR and a high forecast of 285.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IM8N's stock price target?
Price Target
229.59
EUR
According to Wall Street analysts, the average 1-year price target for
IM8N is 229.59 EUR with a low forecast of 191 EUR and a high forecast of 285.51 EUR.
What is the Revenue forecast for Insmed Inc?
Projected CAGR
43%
The compound annual growth rate for Revenue over the next 8 years is 43%.
What is the Gross Profit forecast for Insmed Inc?
Projected CAGR
45%
The compound annual growth rate for Gross Profit over the next 8 years is 45%.